[No standalone website (unbranded, no questionnaire)] A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL)

How to apply

Determine if a study site for this clinical trial is near you. Contact the study to apply.

Find a Study Site

Study’s contact

Call center

866-572-6436

Email address

medinfo@amgen.com

Condition

Chemotherapy-induced Thrombocytopenia

Treatment type

Interventional

Investigational product

Romiplostim

Phase

Phase 3

Sponsor

Amgen

ClinicalTrials.gov identifier

NCT03362177

Study number

20140346

Understanding clinical trials

Get answers to your questions about clinical trials.

About the study

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects with Gastrointestinal or Colorectal Cancer

Who can take part?

You may be eligible to participate in the study if you meet the following criteria:

For a full list of inclusion/exclusion criteria, please visit ClinicalTrials.gov

Study locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to apply

Determine if a study site for this clinical trial is near you. Contact the study to apply.

Find a Study Site